自引率: 4.8%
被引量: 16724
通过率: 暂无数据
审稿周期: 2
版面费用: 暂无数据
国人发稿量: 293
投稿须知/期刊简介:
Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly relevant to human disease. Development and evaluation of novel analytical methologies where applicable to clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. In addition to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta - these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters of Scientific Societies; (6) Meeting announcements. Typescripts submitted to Clinica Chimica Acta should not have been published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.
期刊描述简介:
Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly relevant to human disease. Development and evaluation of novel analytical methologies where applicable to clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. In addition to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta - these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters of Scientific Societies; (6) Meeting announcements. Typescripts submitted to Clinica Chimica Acta should not have been published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.
-
Correlation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients.
被引量:- 发表:1970
-
Clinical performance and application of novel serum collection "Ser-Col" device in the practice of laboratory diagnosis of infection diseases and several other immunochemical tests.
被引量:- 发表:1970
-
Defining age-specific reference intervals for biomarkers distinguishing bacterial from viral infection in paediatrics.
被引量:- 发表:1970
-
Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson's disease.
被引量:- 发表:1970
-
A retrospective analysis of 1600 infertility patients with azoospermia and severe oligozoospermia.
被引量:- 发表:1970